Shots:
Fosun Pharma & AriBio have entered into an exclusive global option agreement for the development, registration, manufacturing, & commercialization of AR1001 for AD, expanding their partnership beyond Greater China & 10 ASEAN countries
AriBio will receive a $60M option fee & retain the right to exercise the option within the agreed period, while Fosun…
